- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 2 x 5AU: Di-glutathione-PhenylArsine(Non-covalent)
5AU.2: 21 residues within 4Å:- Chain A: Y.8, F.9, P.10, V.11, R.14, V.36, W.39, K.45, G.51, Q.52, L.53, P.54, Q.65, S.66, N.67, I.105, Y.109, G.206
- Chain B: D.99
- Ligands: GSH.3, PA0.4
28 PLIP interactions:26 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.9, A:F.9, A:F.9, A:V.11, A:V.11, A:Q.52
- Hydrogen bonds: A:W.39, A:Q.52, A:L.53, A:L.53, A:Q.65, A:Q.65, A:Q.65, A:S.66
- Water bridges: A:R.14, A:R.14, A:K.45, A:K.45, A:Q.65, A:N.67, A:N.67, A:N.67, B:D.99, B:D.99
- Salt bridges: A:R.14, A:R.14, A:K.45, A:K.45
5AU.7: 21 residues within 4Å:- Chain A: D.99
- Chain B: Y.8, F.9, P.10, V.11, R.14, V.36, W.39, K.45, G.51, Q.52, L.53, P.54, Q.65, S.66, N.67, I.105, Y.109, G.206
- Ligands: GSH.8, PA0.9
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:F.9, B:F.9, B:V.11, B:V.11, B:Q.52, B:Y.109
- Hydrogen bonds: B:W.39, B:Q.52, B:L.53, B:L.53, B:Q.65, B:Q.65, B:Q.65, B:S.66, B:S.66
- Water bridges: B:R.14, B:R.14, B:Q.65, B:N.67, B:E.98
- Salt bridges: B:R.14, B:R.14, B:K.45
- 2 x GSH: GLUTATHIONE(Non-covalent)
GSH.3: 13 residues within 4Å:- Chain A: Y.8, F.9, R.14, W.39, K.45, G.51, Q.52, L.53, P.54, Q.65, S.66
- Chain B: D.99
- Ligands: 5AU.2
16 PLIP interactions:14 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:W.39, A:Q.52, A:L.53, A:L.53, A:L.53, A:Q.65, A:S.66, B:D.99
- Water bridges: A:R.14, A:L.53, A:Q.65, A:N.67, A:N.67, B:D.99
- Salt bridges: A:R.14, A:K.45
GSH.8: 14 residues within 4Å:- Chain A: D.99
- Chain B: Y.8, F.9, R.14, W.39, K.45, G.51, Q.52, L.53, P.54, Q.65, S.66, N.67
- Ligands: 5AU.7
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:W.39, B:Q.52, B:L.53, B:L.53, B:Q.65, B:Q.65, B:S.66, B:S.66
- Water bridges: B:R.14, B:Q.65, B:Q.65, B:N.67, B:N.67
- Salt bridges: B:R.14, B:K.45
- 2 x PA0: Phenylarsine oxide(Non-covalent)
PA0.4: 7 residues within 4Å:- Chain A: R.14, C.102, I.105, S.106, T.110
- Chain B: C.102
- Ligands: 5AU.2
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.105
PA0.9: 8 residues within 4Å:- Chain A: C.102, K.103
- Chain B: R.14, C.102, I.105, S.106, T.110
- Ligands: 5AU.7
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:I.105
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parker, L.J. et al., Visualisation of Organoarsenic Human Glutathione Transferase P1-1 Complexes: Metabolism of Arsenic-based Therapeutics. To Be Published
- Release Date
- 2016-12-07
- Peptides
- Glutathione S-transferase P: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 2 x 5AU: Di-glutathione-PhenylArsine(Non-covalent)
- 2 x GSH: GLUTATHIONE(Non-covalent)
- 2 x PA0: Phenylarsine oxide(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parker, L.J. et al., Visualisation of Organoarsenic Human Glutathione Transferase P1-1 Complexes: Metabolism of Arsenic-based Therapeutics. To Be Published
- Release Date
- 2016-12-07
- Peptides
- Glutathione S-transferase P: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B